{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:50:08Z","timestamp":1783925408832,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T00:00:00Z","timestamp":1576627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00259-019-04649-1","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T17:02:42Z","timestamp":1576688562000},"page":"1564-1575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET\/CT and circulating tumor DNA"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1988-0058","authenticated-orcid":false,"given":"Christian","family":"Schmidkonz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Krumbholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Atzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa Ida","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Prante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Ritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"R\u00f6ssig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"B\u00e4uerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Kuwert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Metzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,18]]},"reference":[{"issue":"4","key":"4649_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/CCO.0b013e328303ba1d","volume":"20","author":"JA Ludwig","year":"2008","unstructured":"Ludwig JA. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol. 2008;20(4):412\u20138.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"4649_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/cncr.10192","volume":"94","author":"C Rodriguez-Galindo","year":"2002","unstructured":"Rodriguez-Galindo C, Billups CA, Kun LE, Rao BN, Pratt CB, Merchant TE, et al. Survival after recurrence of Ewing tumors: the St. Jude children's research hospital experience, 1979\u20131999. Cancer. 2002;94(2):561\u20139.","journal-title":"Cancer."},{"issue":"2","key":"4649_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1200\/JCO.2017.74.7402","volume":"36","author":"AS Pappo","year":"2017","unstructured":"Pappo AS, Dirksen U. Rhabdomyosarcoma, Ewing sarcoma, and other round cell sarcomas. J Clin Oncol. 2017;36(2):168\u201379.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4649_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0003-x","volume":"4","author":"TG Gr\u00fcnewald","year":"2018","unstructured":"Gr\u00fcnewald TG, Cidre-Aranaz F, Surdez D, Tomazou EM, de \u00c1lava E, Kovar H, et al. Ewing sarcoma (Primer). Nat Rev Dis Primers. 2018;4(1):5.","journal-title":"Nat Rev Dis Primers"},{"issue":"20","key":"4649_CR5","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1200\/JCO.2009.22.9864","volume":"28","author":"R Ladenstein","year":"2010","unstructured":"Ladenstein R, P\u00f6tschger U, Le Deley MC, Whelan J, Paulussen M, Oberlin O, et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol. 2010;28(20):3284\u201391.","journal-title":"J Clin Oncol"},{"issue":"4","key":"4649_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/pbc.23040","volume":"57","author":"M Stahl","year":"2011","unstructured":"Stahl M, Ranft A, Paulussen M, B\u00f6lling T, Vieth V, Bielack S, et al. Risk of recurrence and survival after relapse in patients with Ewing sarcoma. Pediatr Blood Cancer. 2011;57(4):549\u201353.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4649_CR7","doi-asserted-by":"publisher","first-page":"11000","DOI":"10.1038\/s41598-019-46721-8","volume":"9","author":"S Bosma","year":"2019","unstructured":"Bosma S, Lancia C, Rueten-Budde A, Ranft A, Gelderblom H, Fiocco M, et al. Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery. Sci Rep. 2019;9(1):11000.","journal-title":"Sci Rep"},{"issue":"27","key":"4649_CR8","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1200\/JCO.2014.59.5256","volume":"33","author":"N Gaspar","year":"2015","unstructured":"Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley M-C, et al. Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol. 2015;33(27):3036\u201346.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4649_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1148\/radiology.174.2.2296660","volume":"174","author":"G Pan","year":"1990","unstructured":"Pan G, Raymond A, Carrasco C, Wallace S, Kim E, Shirkhoda A, et al. Osteosarcoma: MR imaging after preoperative chemotherapy. Radiology. 1990;174(2):517\u201326.","journal-title":"Radiology."},{"issue":"4","key":"4649_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2214\/ajr.154.4.2107673","volume":"154","author":"HC Holscher","year":"1990","unstructured":"Holscher HC, Bloem J, Nooy M, Taminiau A, Eulderink F, Hermans J. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. AJR Am J Roentgenol. 1990;154(4):763\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"4649_CR11","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1007\/s00259-010-1484-3","volume":"37","author":"T Denecke","year":"2010","unstructured":"Denecke T, Hundsd\u00f6rfer P, Misch D, Steffen IG, Sch\u00f6nberger S, Furth C, et al. Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters. Eur J Nucl Med Mol Imaging. 2010;37(10):1842\u201353.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"4649_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/BF00391442","volume":"113","author":"V Gobel","year":"1987","unstructured":"Gobel V, Jurgens H, Etspuler G, Kemperdick H, Jungblut RM, Stienen U, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol. 1987;113(2):187\u201391.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"4649_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1023\/A:1008357018737","volume":"10","author":"HW Hense","year":"1999","unstructured":"Hense HW, Ahrens S, Paulussen M, Lehnert M, Jurgens H. Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI)CESS studies. Ann Oncol. 1999;10(9):1073\u20137.","journal-title":"Ann Oncol"},{"issue":"4","key":"4649_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/0284186X.2017.1398411","volume":"57","author":"O Kasalak","year":"2018","unstructured":"Kasalak O, Overbosch J, Glaudemans A, Boellaard R, Jutte PC, Kwee TC. Primary tumor volume measurements in Ewing sarcoma: MRI inter- and intraobserver variability and comparison with FDG-PET. Acta Oncol. 2018;57(4):534\u201340.","journal-title":"Acta Oncol"},{"issue":"3","key":"4649_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1148\/radiology.175.3.2188300","volume":"175","author":"R Erlemann","year":"1990","unstructured":"Erlemann R, Sciuk J, Bosse A, Ritter J, Kusnierz-Glaz CR, Peters PE, et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology. 1990;175(3):791\u20136.","journal-title":"Radiology."},{"issue":"4","key":"4649_CR16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2214\/ajr.157.4.1892044","volume":"157","author":"BD Fletcher","year":"1991","unstructured":"Fletcher BD. Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation. AJR Am J Roentgenol. 1991;157(4):825\u201333.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"4649_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bjh.14734","volume":"178","author":"EJ Dann","year":"2017","unstructured":"Dann EJ, Bairey O, Bar-Shalom R, Mashiach T, Barzilai E, Kornberg A, et al. Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET\/CT is beneficial: a prospective multicentre trial of 355 patients. Br J Haematol. 2017;178(5):709\u201318.","journal-title":"Br J Haematol"},{"issue":"8","key":"4649_CR18","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2967\/jnumed.116.185314","volume":"58","author":"EA Usmanij","year":"2017","unstructured":"Usmanij EA, Natroshvili T, Timmer-Bonte JNH, Oyen WJG, van der Drift MA, Bussink J, et al. The predictive value of early in-treatment 18F-FDG PET\/CT response to chemotherapy in combination with bevacizumab in advanced nonsquamous non\u2013small cell lung cancer. J Nucl Med. 2017;58(8):1243\u20138.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"4649_CR19","doi-asserted-by":"publisher","first-page":"34S","DOI":"10.2967\/jnumed.115.157875","volume":"57","author":"S Avril","year":"2016","unstructured":"Avril S, Muzic RF, Plecha D, Traughber BJ, Vinayak S, Avril N. 18F-FDG PET\/CT for monitoring of treatment response in breast Cancer. J Nucl Med. 2016;57(Suppl 1):34S\u20139S.","journal-title":"J Nucl Med"},{"issue":"6","key":"4649_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s002590050570","volume":"27","author":"CJ Hoekstra","year":"2000","unstructured":"Hoekstra CJ, Paglianiti I, Hoekstra OS, Smit EF, Postmus PE, Teule GJJ, et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med. 2000;27(6):731\u201343.","journal-title":"Eur J Nucl Med"},{"key":"4649_CR21","doi-asserted-by":"crossref","unstructured":"Frings V, Velden FHPv, Velasquez LM, Hayes W, Ven PMvd, Hoekstra OS, et al. Repeatability of metabolically active tumor volume measurements with FDG PET\/CT in advanced gastrointestinal malignancies: a multicenter study. Radiology. 2014;273(2):539\u2013548.","DOI":"10.1148\/radiol.14132807"},{"issue":"11","key":"4649_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/00003072-200011000-00004","volume":"25","author":"C Franzius","year":"2000","unstructured":"Franzius C, Sciuk J, Brinkschmidt C, J\u00dcRGENS H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med. 2000;25(11):874\u201381.","journal-title":"Clin Nucl Med"},{"issue":"34","key":"4649_CR23","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1200\/JCO.2005.01.7079","volume":"23","author":"DS Hawkins","year":"2005","unstructured":"Hawkins DS, Schuetze SM, Butrynski JE, Rajendran JG, Vernon CB III, EUC, et al. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol. 2005;23(34):8828\u201334.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4649_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00259-016-3478-2","volume":"44","author":"PS van Rossum","year":"2017","unstructured":"van Rossum PS, Fried DV, Zhang L, Hofstetter WL, Ho L, Meijer GJ, et al. The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma. Eur J Nucl Med Mol Imaging. 2017;44(1):71\u201380.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"4649_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00259-016-3315-7","volume":"43","author":"NG Mikhaeel","year":"2016","unstructured":"Mikhaeel NG, Smith D, Dunn JT, Phillips M, M\u00f8ller H, Fields PA, et al. Combination of baseline metabolic tumour volume and early response on PET\/CT improves progression-free survival prediction in DLBCL. Eur J Nucl Med Mol Imaging. 2016;43(7):1209\u201319.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"4649_CR26","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1007\/s00330-009-1443-1","volume":"19","author":"T B\u00e4uerle","year":"2009","unstructured":"B\u00e4uerle T, Semmler W. Imaging response to systemic therapy for bone metastases. Eur Radiol. 2009;19(10):2495\u2013507.","journal-title":"Eur Radiol"},{"issue":"11\u201312","key":"4649_CR27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.18632\/genesandcancer.86","volume":"6","author":"DJ Elzi","year":"2015","unstructured":"Elzi DJ, Song M, Houghton PJ, Chen Y, Shiio Y. The role of FLI-1-EWS, a fusion gene reciprocal to EWS-FLI-1, in Ewing sarcoma. Genes Cancer. 2015;6(11\u201312):452.","journal-title":"Genes Cancer"},{"issue":"32","key":"4649_CR28","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1038\/onc.2010.205","volume":"29","author":"EC Toomey","year":"2010","unstructured":"Toomey EC, Schiffman JD, Lessnick SL. Recent advances in the molecular pathogenesis of Ewing's sarcoma. Oncogene. 2010;29(32):4504.","journal-title":"Oncogene."},{"issue":"2","key":"4649_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1172\/JCI117360","volume":"94","author":"M Giovannini","year":"1994","unstructured":"Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, et al. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. J Clin Invest. 1994;94(2):489\u201396.","journal-title":"J Clin Invest"},{"issue":"17","key":"4649_CR30","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1158\/1078-0432.CCR-15-3028","volume":"22","author":"M Krumbholz","year":"2016","unstructured":"Krumbholz M, Hellberg J, Steif B, B\u00e4uerle T, Gillmann C, Fritscher T, et al. Genomic EWSR1 fusion sequence as highly sensitive and dynamic plasma tumor marker in Ewing sarcoma. Clin Cancer Res. 2016;22(17):4356\u201365.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4649_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2967\/jnumed.108.058461","volume":"50","author":"CM Costelloe","year":"2009","unstructured":"Costelloe CM, Macapinlac HA, Madewell JE, Fitzgerald NE, Mawlawi OR, Rohren EM, et al. 18F-FDG PET\/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 2009;50(3):340\u20137.","journal-title":"J Nucl Med"},{"issue":"9","key":"4649_CR32","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s00259-014-2756-0","volume":"41","author":"B Khiewvan","year":"2014","unstructured":"Khiewvan B, Macapinlac HA, Lev D, McCutcheon IE, Slopis JM, Al Sannaa G, et al. The value of 18 F-FDG PET\/CT in the management of malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging. 2014;41(9):1756\u201366.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"4649_CR33","doi-asserted-by":"publisher","first-page":"e56408","DOI":"10.1371\/journal.pone.0056408","volume":"8","author":"M Berger","year":"2013","unstructured":"Berger M, Dirksen U, Braeuninger A, Koehler G, Juergens H, Krumbholz M, et al. Genomic EWS-FLI1 fusion sequences in Ewing sarcoma resemble breakpoint characteristics of immature lymphoid malignancies. PLoS One. 2013;8(2):e56408.","journal-title":"PLoS One"},{"issue":"2","key":"4649_CR34","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1148\/radiol.2016142043","volume":"280","author":"O Joo Hyun","year":"2016","unstructured":"Joo Hyun O, Lodge MA, Wahl RL. Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0. Radiology. 2016;280(2):576.","journal-title":"Radiology"},{"issue":"1","key":"4649_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37\u201346.","journal-title":"Educ Psychol Meas"},{"key":"4649_CR36","doi-asserted-by":"crossref","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977:159\u201374.","DOI":"10.2307\/2529310"},{"issue":"8","key":"4649_CR37","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/pbc.25042","volume":"61","author":"M Rasper","year":"2014","unstructured":"Rasper M, Jabar S, Ranft A, J\u00fcrgens H, Amler S, Dirksen U. The value of high-dose chemotherapy in patients with first relapsed Ewing sarcoma. Pediatr Blood Cancer. 2014;61(8):1382\u20136.","journal-title":"Pediatr Blood Cancer"}],"updated-by":[{"DOI":"10.1007\/s00259-019-04672-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000}}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04649-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04649-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04649-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T01:02:51Z","timestamp":1608166971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04649-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,18]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4649"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04649-1","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00259-019-04672-2","asserted-by":"object"}]},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,18]]},"assertion":[{"value":"2 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author names and family names of the originally published article was inversed. Correct presentation is presented here.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individuals who participated in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}